Contineum Therapeutics CTNM
NASDAQ CTNM
$10.77 +0.21 (+1.99%)
At close: Nov 11, 2026 · 4:00 PM EST

Contineum Therapeutics (CTNM) Capital Expenditures (2023 - 2026)

Updated

Analysis

Contineum Therapeutics (CTNM) Capital Expenditures (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Contineum Therapeutics 405.40 Mn -584.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6,000.00
Mar 31, 2026 312,000.00
Dec 31, 2025 42,000.00
Sep 30, 2025 98,000.00
Jun 30, 2025 44,000.00
Mar 31, 2025 47,000.00
Dec 31, 2024 166,000.00
Sep 30, 2024 82,000.00
Jun 30, 2024 119,000.00
Mar 31, 2024 147,000.00
Dec 31, 2023 309,000.00
Sep 30, 2023 22,000.00
Jun 30, 2023 31,000.00
Mar 31, 2023 52,000.00
API Access

Contineum Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CTNM&period=max&api_key=YOUR_API_KEY